Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's (Q73300396)
Jump to navigation
Jump to search
scientific article published on 01 December 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's |
scientific article published on 01 December 2000 |
Statements
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study (English)
R C Seeger
K K Matthay
M F Ozkaynak
P M Sondel
M D Krailo
J Gan
B Javorsky
R A Reisfeld